Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Periampullary Carcinoma Non-Resectable”

4 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 4 of 4 results

Not applicableStudy completedNCT02474914
What this trial is testing

Octreotide in the Prevention of Postoperative Complications After Pancreaticoduodenectomy

Who this might be right for
Periampullary Carcinoma Resectable
Mansoura University 104
Not applicableUnknownNCT03063554
What this trial is testing

EUS BD vs ERCP TP for Pancreatic Cancer

Who this might be right for
Pancreatic CancerPancreatic AdenocarcinomaBiliary Tract Neoplasms+4 more
Weill Medical College of Cornell University 120
Testing effectiveness (Phase 2)Ended earlyNCT01229111
What this trial is testing

Cediranib Maleate and Combination Chemotherapy in Treating Patients With Advanced Biliary Cancers

Who this might be right for
Adult Primary Cholangiocellular CarcinomaAdvanced Adult Primary Liver CancerCholangiocarcinoma of the Extrahepatic Bile Duct+8 more
National Cancer Institute (NCI) 14
Testing effectiveness (Phase 2)UnknownNCT01811277
What this trial is testing

SOX Sequential S-1 in Advanced Biliary Tract Carcinoma（BTC）and Pancreatic Cancer

Who this might be right for
Biliary Tract CancerPeriampullary AdenocarcinomaPancreatic Cancer
Peking University 40